1. Home
  2. DMLP vs NBTX Comparison

DMLP vs NBTX Comparison

Compare DMLP & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMLP

Dorchester Minerals L.P.

N/A

Current Price

$27.53

Market Cap

1.5B

Sector

Energy

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$30.45

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DMLP
NBTX
Founded
2003
2003
Country
United States
France
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
DMLP
NBTX
Price
$27.53
$30.45
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $54.24
AVG Volume (30 Days)
83.8K
★ 126.0K
Earning Date
11-05-2026
09-24-2026
Dividend Yield
★ 10.24%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.75
N/A
Revenue
★ $152,832,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$50.69
P/E Ratio
$23.17
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$20.85
$19.14
52 Week High
$31.08
$57.14

Technical Indicators

Market Signals
Indicator
DMLP
NBTX
Relative Strength Index (RSI) 31.39 52.98
Support Level $26.43 $30.15
Resistance Level $28.39 $35.17
Average True Range (ATR) 0.77 1.97
MACD -0.38 0.47
Stochastic Oscillator 5.23 67.29

Price Performance

Historical Comparison
DMLP
NBTX

About DMLP Dorchester Minerals L.P.

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: